Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Obrenovic, B. (6506095227)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Clinical and functional evaluation of the Carbomedics Prosthetic Heart Valve in the mitral position. Preliminary results
    (1990)
    Subotic, S. (57163547100)
    ;
    Petrovic, P. (57198305352)
    ;
    Boskovic, D. (59808752300)
    ;
    Obrenovic, B. (6506095227)
    ;
    Sindjelic, R. (6602803313)
    ;
    Lovric, Z. (55441063100)
    ;
    Djukic, P. (6508205447)
    ;
    Vranes, M. (6701667966)
    ;
    Curcic, S. (6701473338)
    ;
    Matic, A. (7003674642)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Life-threatening bleeding due to an acquired inhibitor to factor XII-XI successfully treated with 'activated' prothrombin complex concentrate (FEIBA)
    (1982)
    Rolovic, Z. (7006321033)
    ;
    Elezovic, I. (12782840600)
    ;
    Obrenovic, B. (6506095227)
    ;
    Rizza, C. (58439940000)
    Five instances of inhibitor to factor XII-XI have been reported so far. These have arisen in two women suffering from systemic lupus erythematosus and in three patients with Waldenstrom macroglobulinaemia. None of these patients had a bleeding tendency. The authors believe that it is of interest to report a 45-year-old female with an 18 years history of a bleeding tendency, who developed life-threatening vaginal bleeding following total hysterectomy for rupture of an ovarian cyst. Coagulation studies revealed a prolonged whole blood clotting time of 19 min and an activated partial thromboplastin time of 199 s (control 40 s). Further experiments showed that the patient's plasma at the dilution of 1:32 inhibited a contact product preparation thus indicating an inhibitor to factor XII-XI. The patient was treated with a variety of blood products without success but the administration of FEIBA 60 units/kg/d for 4 d was followed by the arrest of bleeding. The patient recovered completely. She had no evidence of an associated systemic disease but the inhibitor is still present in the plasma.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback